Search results for "PLUS"

showing 10 items of 248 documents

Hot spots and gluon field fluctuations as causes of eccentricity in small systems

2021

We calculate eccentricities in high energy proton-nucleus collisions, by calculating correlation functions of the energy density field of the Glasma immediately after the collision event at proper time tau = 0. We separately consider the effects of color charge and geometrical hot spot fluctuations, analytically performing the averages over both in a dilute-dense limit. We show that geometric fluctuations of hot spots inside the proton are the dominant source of eccentricity whereas color charge fluctuations only give a negligible correction. The size and number of hot spots are the most important parameters characterizing the eccentricities.

Nuclear TheoryField (physics)ProtonAZIMUTHAL ANISOTROPIESFLOWmedia_common.quotation_subjectFOS: Physical sciencesHot spot (veterinary medicine)hiukkasfysiikka114 Physical sciences01 natural sciencesNuclear Theory (nucl-th)High Energy Physics - Phenomenology (hep-ph)0103 physical sciencesProper timeEccentricity (behavior)LONG-RANGEHARMONICSNuclear Experiment010306 general physicsPLUS PB COLLISIONSGluon fieldmedia_commonPROTON-LEAD COLLISIONSPhysics010308 nuclear & particles physicskvarkki-gluoniplasmaANGULAR-CORRELATIONSComputational physicsHigh Energy Physics - PhenomenologyNEAR-SIDEAstrophysics::Earth and Planetary AstrophysicsHIGH TRANSVERSE-MOMENTUMPPBEvent (particle physics)Color chargePhysical Review D
researchProduct

CP-violating Higgs boson production in association with three jets via gluon fusion

2014

In these proceedings, we present results for Higgs production at the LHC via gluon fusion with triple real emission corrections and the validity range of the heavy-top effective theory approximation for this process. For a general CP-violating Higgs boson, we show that bottom-quark loop corrections in combination with large values of $\tan \beta $ significantly distort differential distributions.

Nuclear and High Energy PhysicsParticle physicsHigh Energy Physics::LatticeFOS: Physical sciences01 natural sciencesHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)0103 physical sciencesEffective field theoryHiggs plus jets010306 general physicsPhysicsFusionLarge Hadron Collider010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyValidity rangeGluonHigh Energy Physics - PhenomenologyCollider PhysicsHiggs bosonCP violationProduction (computer science)High Energy Physics::Experiment
researchProduct

Search for neutral Higgs bosons decaying into four taus at LEP2

2010

A search for the production and non-standard decay of a Higgs boson, h, into four taus through intermediate pseudoscalars, a, is conducted on 683 pb-1 of data collected by the ALEPH experiment at centre-of-mass energies from 183 to 209 GeV. No excess of events above background is observed, and exclusion limits are placed on the combined production cross section times branching ratio, β2 = σ(e+e -→Zh)/σSM(e+e-→Zh) ×B(h→aa)×B(a→τ+τ-) 2. For mh 1 is excluded at the 95% confidence level.

Nuclear and High Energy PhysicsParticle physicsTeoria quàntica de campsFOS: Physical sciences01 natural scienceshiggs bosonHigh Energy Physics - ExperimentALEPH Experimente+-e-ExperimentsHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)Collisions (Nuclear physics)Violació CP (Física nuclear)0103 physical sciencesCERN[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Teoria quàntica010306 general physicsALEPH experimentBosonPhysicse+-e- ExperimentsHiggs bosonsALEPH Experiment; CERN; higgs boson010308 nuclear & particles physicsBranching fractionSettore FIS/01 - Fisica SperimentaleSigmaRelativity (Physics)Relativitat (Física)e plus -e- ExperimentsQuantum field theoryHigh Energy Physics - PhenomenologyBosons de HiggsCol·lisions (Física nuclear)Quantum theoryHiggs bosonPhysique des particules élémentairesProduction (computer science)Particle Physics - ExperimentE+-e- ExperimentsCP violation (Nuclear physics)
researchProduct

Evidence of octupole-phonons at high spin in 207Pb

2019

A lifetime measurement of the 19/2 state in Pb has been performed using the Recoil Distance Doppler-Shift (RDDS) method. The nuclei of interest were produced in multi-nucleon transfer reactions induced by a Pb beam impinging on a Mo enriched target. The beam-like nuclei were detected and identified in terms of their atomic mass number in the VAMOS++ spectrometer while the prompt γ rays were detected by the AGATA tracking array. The measured large reduced transition probability B(E3,19/2→13/2)=40(8) W.u. is the first indication of the octupole phonon at high spin in Pb. An analysis in terms of a particle-octupole-vibration coupling model indicates that the measured B(E3) value in Pb is compa…

Nuclear and High Energy PhysicsPlunger devicePhononNuclear TheoryOctupole phonon[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]gamma-Ray trackingγ -Ray tracking01 natural sciences7. Clean energyRecoilVAMOS++ spectrometerAGATA spectrometer; Nuclear deformation; Octupole phonon; Plunger device; VAMOS++ spectrometer; γ-Ray tracking0103 physical sciencesPhysics::Atomic PhysicsAGATA spectrometerNuclear Experiment010306 general physicsSpin (physics)PhysicsVAMOS plus plus spectrometer010308 nuclear & particles physicsγ-Ray trackinglcsh:QC1-999Nuclear deformationAtomic physicslcsh:Physics
researchProduct

Conceptual design of the AGATA 1$\pi$ array at GANIL

2017

The Advanced GAmma Tracking Array (AGATA) has been installed at the GANIL facility, Caen-France. This setup exploits the stable and radioactive heavy-ions beams delivered by the cyclotron accelerator complex of GANIL. Additionally, it benefits from a large palette of ancillary detectors and spectrometers to address in-beam γ-ray spectroscopy of exotic nuclei. The set-up has been designed to couple AGATA with a magnetic spectrometer, charged-particle and neutron detectors, scintillators for the detection of high-energy γ rays and other devices such as a plunger to measure nuclear lifetimes. In this paper, the design and the mechanical characteristics of the set-up are described. Based on sim…

Nuclear and High Energy PhysicsPlunger devicePhysics::Instrumentation and DetectorsAstrophysics::High Energy Astrophysical PhenomenaCyclotronScintillator[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Accelerator Physics and InstrumentationTracking (particle physics)01 natural sciences7. Clean energylaw.inventionNuclear physicsConceptual designlaw0103 physical sciencesPARIS LaBr3 detectorNeutron detectionPulse shape analysisAGATA spectrometer010306 general physicsNuclear ExperimentInstrumentationPhysicsSpectrometerVAMOS plus plus spectrometer010308 nuclear & particles physicsDetectorFATIMA LaBr3 detectorAcceleratorfysik och instrumenteringDIAMANT detectorNEDA detectorAuthor Keywords:AGATA spectrometerPhysics::Accelerator PhysicsAGATAgamma-ray trackingGANIL facility
researchProduct

Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Populati…

2022

Background: Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm- NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic b…

Nutrition and DieteticsEndocrinology Diabetes and MetabolismPes corporalPREDIMED-Plus studyBody weightfront of pack food labelingCardiovascular risk factorFront of pack food labelingFSAm-NPS dietary indexCardiovascular systembody weightcardiovascular risk factorSistema cardiovascularFood ScienceFrontiers in nutrition
researchProduct

A Model of Multiproduct Price Competition

1997

Abstract We provide a simple model of price competition in a multiproduct oligopoly market. The products are of general nature. We find that a pure strategy equilibrium exists and every equilibrium consumption maximizes the total social surplus. Consumers are characterized by a set function which determines their willingness to pay for every subset of products. If this function is convex, the set of equilibrium prices coincides with the core of a cooperative game generated by this set function and the firms extract total industry surplus. If it is concave, the only equilibrium price of a product is its marginal contribution to the consumer's total willingness to pay. Journal of Economic Lit…

OligopolyMicroeconomicsConsumption (economics)Competition (economics)Economics and EconometricsCore (game theory)StrategyWillingness to paySet functionEconomicsEconomic surplusJournal of Economic Theory
researchProduct

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy

2010

Purpose: Knowledge of prognostic factors for advanced non-small-cell lung cancer (NSCLC) patients eligible for second-line treatment is scarce. The aim of this study was to assess the prognostic role of a number of routinely collected clinical variables and to provide a summary index to discriminate patients according to probability of survival.Methods: individual data from nine randomised trials of second-line treatment in advanced NSCLC were analysed. Primary end-point was overall survival (OS). Cox model, stratified by trial, was used for multivariate analyses, and a prognostic index was provided and validated according to an internal/external procedure.Results: Out of 1239 patients, 119…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyMultivariate analysisLung NeoplasmsWEEKLY DOCETAXELIRINOTECANCOMBINATION CHEMOTHERAPYAntineoplastic AgentsERLOTINIBPrognostic factorsNSCLCTHERAPYPooled analysisPLUS GEMCITABINEInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansStage (cooking)Lung cancerEVERY 3 WEEKSAgedNeoplasm StagingRandomized Controlled Trials as TopicAged 80 and overPerformance statusProportional hazards modelbusiness.industryAge FactorsCombination chemotherapyPHASE-III TRIALMiddle Agedmedicine.diseasePrognosisTreatment OutcomeOncologyMeta-analysisPrognostic scoreCOMPARING DOCETAXELSecond-line treatmentAdenocarcinomaFemalebusinessEpidemiologic MethodsNon-small-cell lung cancerEuropean Journal of Cancer
researchProduct

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts

2018

Source at https://doi.org/10.1186/s13058-018-1073-0. Licensed CC BY-NC-ND 4.0. Background: Few published breast cancer (BC) risk prediction models consider the heterogeneity of predictor variables between estrogen-receptor positive (ER+) and negative (ER-) tumors. Using data from two large cohorts, we examined whether modeling this heterogeneity could improve prediction. Methods: We built two models, for ER+ (ModelER+) and ER- tumors (ModelER-) , respectively, in 281,330 women (51% postmenopausal at recruitment) from the European Prospective Investigation into Cancer and Nutrition cohort. Discrimination (C-statistic) and calibration (the agreement between predicted and observed tumor risks)…

OncologyHORMONE-REPLACEMENT THERAPYmedicine.medical_treatmentWHI0302 clinical medicineBreast cancerRisk FactorsEstrogen receptor030212 general & internal medicineProspective StudiesProspective cohort study2. Zero hungerIncidenceHormone replacement therapy (menopause)Middle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisRisk prediction3. Good healthEuropean Prospective Investigation into Cancer and NutritionMenopausePOSTMENOPAUSAL WOMENReceptors EstrogenPLUS PROGESTIN030220 oncology & carcinogenesisCohortFemaleRisk assessmentResearch Articlemedicine.medical_specialtyMODELSAntineoplastic AgentsBreast NeoplasmsEstrògenslcsh:RC254-282Models BiologicalRisk AssessmentVALIDATIONCàncer de mamaMAMMOGRAPHY03 medical and health sciencesBreast cancerInternal medicinemedicineHumansOncology & CarcinogenesisCancer och onkologiVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762business.industryMORTALITYKirurgiProspective cohortmedicine.diseaseEstrogenVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Cancer and OncologySurgerybusinessEPIC1112 Oncology And CarcinogenesisBody mass indexFollow-Up StudiesBreast Cancer Research : BCR
researchProduct

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

2014

none 29 no Background: Aim was to select naïve patients with genotype 1 chronic hepatitis C having a high probability of response to Peg-interferon. +. ribavirin therapy. Methods: In 1073 patients (derivation cohort), predictors of rapid and sustained virological response were identified by logistic analysis; regression coefficients were used to generate prediction models for sustained virological response. Probabilities at baseline and treatment week 4 were utilized to develop a decision rule to select patients with high likelihood of response. The model was then validated in 423 patients (validation cohort). Results: In the derivation cohort, 257 achieved rapid virological response and 8…

OncologyMaleHepacivirusPredictive Value of Testchronic hepatitis C; prediction model of response; peginterferon plus ribavirin dual therapyHepacivirusPolyethylene GlycolPolyethylene Glycolschemistry.chemical_compoundGenotypeViralChronicRapid virological responseDrug CarrierChronic hepatitisSettore MED/12 - GastroenterologiaDrug CarriersbiologyGastroenterologyRecombinant ProteinMiddle AgedViral LoadPrognosisHepatitis CRecombinant ProteinsHCV infectionTreatment OutcomePredictive value of testsCombinationRNA ViralDrug Therapy CombinationFemaleChronic hepatitis; HCV infection; Peg-interferon and ribavirin treatment; Predictors of sustained virological response rapid virological response; Adult; Antiviral Agents; Drug Carriers; Drug Therapy Combination; Female; Genotype; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Prognosis; RNA Viral; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Hepatology; GastroenterologyViral loadHumanAdultmedicine.medical_specialtyGenotypePrognosiAlpha interferonPredictors of sustained virological response rapid virological responseReal-Time Polymerase Chain ReactionAntiviral AgentsDrug TherapyPredictive Value of TestsInternal medicinePredictors of sustained virological responseLinear regressionRibavirinmedicinechronic hepatitis CHumansAntiviral AgentHCV infection; Predictors of sustained virological response Rapid virological response; Peg-interferon and ribavirin treatment; Chronic hepatitisHepaciviruHepatologybusiness.industryRibavirinInterferon-alphaHepatologyHepatitis C Chronicbiology.organism_classificationchemistryImmunologyChronic hepatitiRNAprediction model of responsepeginterferon plus ribavirin dual therapybusinessPeg-interferon and ribavirin treatmentDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct